alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
EXHIBIT 99.9 VIA EDGAR  TO: United States Securities and Exchange Commission  Re: Asanko Gold Inc. (the "Company") Annual Report on Form 40-F Consent of Expert This consent is provided in connection with the Company's annual report on Form 40-F for the financial year ended December 31, 2013, and any amendments thereto (the Annual Report), as filed by the Company with the United States Securities and Exchange Commission.  The Annual Report incorporates by reference, among other things, the Companys Annual Information Form for the financial year ended December 31, 2013 (the Annual Information Form). I, Charles Muller, DO HEREBY CONSENT, to:  · the use of my name and the disclosure of my involvement in the preparation of information that forms the basis for disclosure of a technical and scientific nature related to the Companys Esaase Gold Project, Ghana, contained in the Annual Information Form, and  · the inclusion and incorporation by reference of such information in the Annual Report.  Dated March 28, 2014  /s/ Charles MullerCharles Johannes Muller B.Sc. (Hons) (Geol.), Pr. Sci. Nat., MGSSA Director, Minxcon (Pty) Ltd
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Homeland Security

###### Federal Emergency Management Agency

          - [Internal Agency Docket No. FEMA-4488-DR; Docket ID FEMA-2022-0001]

# AGENCY:

Federal Emergency Management Agency, DHS.

# ACTION:

Notice.

# SUMMARY:

This notice amends the notice of a major disaster declaration for the State of New Jersey (FEMA-4488-DR), dated March 25, 2020, and related determinations.

# DATES:

This change occurred on February 16, 2022.

      ( print page 12478)    

# FOR FURTHER INFORMATION CONTACT:

Dean Webster, Office of Response and Recovery, Federal Emergency Management Agency, 500 C Street SW, Washington, DC 20472, (202) 646-2833.

# SUPPLEMENTARY INFORMATION:

The Federal Emergency Management Agency (FEMA) hereby gives notice that pursuant to the authority vested in the Administrator, under Executive Order 12148, as amended, David Warrington, of FEMA is appointed to act as the Federal Coordinating Officer for this disaster.

This action terminates the appointment of Chad M. Gorman as Federal Coordinating Officer for this disaster.

The following Catalog of Federal Domestic Assistance Numbers (CFDA) are to be used for reporting and drawing funds: 97.030, Community Disaster Loans; 97.031, Cora Brown Fund; 97.032, Crisis Counseling; 97.033, Disaster Legal Services; 97.034, Disaster Unemployment Assistance (DUA); 97.046, Fire Management Assistance Grant; 97.048, Disaster Housing Assistance to Individuals and Households in Presidentially Declared Disaster Areas; 97.049, Presidentially Declared Disaster Assistance—Disaster Housing Operations for Individuals and Households; 97.050, Presidentially Declared Disaster Assistance to Individuals and Households—Other Needs; 97.036, Disaster Grants—Public Assistance (Presidentially Declared Disasters); 97.039, Hazard Mitigation Grant.

Deanne Criswell,

Administrator, Federal Emergency Management Agency.

[FR Doc. 2022-04582 Filed 3-3-22; 8:45 am]

BILLING CODE 9111-23-P
#### Blanche PENNYMON, Appellant, v. UNITED STATES of America, Appellee.

No. 21018.

United States Court of Appeals Ninth Circuit.

Dec. 2, 1966.

Michael Rotberg, of Boyko & Simmons, Los Angeles, Cal, for appellant.

Edwin L. Miller, U. S. Atty., Shelby Gott, Asst. U. S. Atty., San Diego, Cal., for appellee.

Before BARNES, JERTBERG and BROWNING, Circuit Judges.

PER CURIAM.

The sole question raised on this appeal is the sufficiency of the evidence to justify the conviction below. We are convinced the evidence was sufficient to justify the conviction. We affirm.
**Exhibit
      32.1**





**CERTIFICATION
      PURSUANT TO**


**18
      U.S.C. SECTION 1350,**


**AS
      ADOPTED PURSUANT TO**


**SECTION
      906 OF THE SARBANES-OXLEY ACT OF 2002**





In
      connection with the Annual Report of RFG Acquisition II Inc. (the "Company")
      on
      Form 10-KSB for the fiscal year ended December 31, 2006 as filed with the
      Securities and Exchange Commission on the date hereof (the "Report"), I, Richard
      F. Beston, Jr., certify, pursuant to 18 U.S.C. ss. 1350, as adopted pursuant
      to
      ss. 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:





(1)
      The
      Report fully complies with the requirements of section 13(a) or 15(d) of the
      Securities Exchange Act of 1934; and





(2)
      The
      information contained in the Report fairly presents, in all material respects,
      the financial condition and results of operations of the Company.





/s/
                Richard F. Beston, Jr.
              Richard
                F. Beston, Jr.
              Principal
                Executive Officer
              February
                20, 2007
<TABLE> <S> <C>

<ARTICLE> 9
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
COMPANY'S CONSOLIDATED BALANCE SHEETS AND CONSOLIDATED STATEMENTS OF OPERATION 
AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
       
<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-1996
<PERIOD-END>                               SEP-30-1996
<CASH>                                          23,417
<INT-BEARING-DEPOSITS>                              15
<FED-FUNDS-SOLD>                                30,500
<TRADING-ASSETS>                                     0
<INVESTMENTS-HELD-FOR-SALE>                     26,770
<INVESTMENTS-CARRYING>                          19,395
<INVESTMENTS-MARKET>                            18,062
<LOANS>                                        721,892
<ALLOWANCE>                                     14,776
<TOTAL-ASSETS>                                 852,478
<DEPOSITS>                                     783,188
<SHORT-TERM>                                    10,649
<LIABILITIES-OTHER>                              5,708
<LONG-TERM>                                          0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                      1,500
<COMMON>                                         8,367
<OTHER-SE>                                      43,066
<TOTAL-LIABILITIES-AND-EQUITY>                 852,478
<INTEREST-LOAN>                                 45,111
<INTEREST-INVEST>                                3,413
<INTEREST-OTHER>                                     0
<INTEREST-TOTAL>                                48,524
<INTEREST-DEPOSIT>                              23,886
<INTEREST-EXPENSE>                              24,204
<INTEREST-INCOME-NET>                           24,320
<LOAN-LOSSES>                                    1,350
<SECURITIES-GAINS>                                   8
<EXPENSE-OTHER>                                 22,166
<INCOME-PRETAX>                                  3,583
<INCOME-PRE-EXTRAORDINARY>                       3,583
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     2,272
<EPS-PRIMARY>                                      .46
<EPS-DILUTED>                                      .46
<YIELD-ACTUAL>                                    8.32
<LOANS-NON>                                     16,621
<LOANS-PAST>                                     1,517
<LOANS-TROUBLED>                                 2,122
<LOANS-PROBLEM>                                  4,687
<ALLOWANCE-OPEN>                                14,910
<CHARGE-OFFS>                                    1,657
<RECOVERIES>                                       202
<ALLOWANCE-CLOSE>                               14,776
<ALLOWANCE-DOMESTIC>                            14,776
<ALLOWANCE-FOREIGN>                                  0
<ALLOWANCE-UNALLOCATED>                         14,776
        

</TABLE>
```

[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[H.R. 6918 Engrossed in House (EH)]

<DOC>
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
118th CONGRESS
  2d Session
                                H. R. 6918

_______________________________________________________________________

                                 AN ACT

 
To prohibit the Secretary of Health and Human Services from restricting 
                     funding for pregnancy centers.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Supporting Pregnant and Parenting 
Women and Families Act''.

SEC. 2. PROHIBITION ON DISCRIMINATION AGAINST PREGNANCY CENTERS.

    (a) In General.--The Secretary of Health and Human Services may not 
finalize, implement, or enforce, with respect to expenditures for any 
pregnancy center, the modification to section 263.11 of title 45, Code 
of Federal Regulations, as described in the proposed regulation set 
forth beginning on page 67697 of volume 88 of the Federal Register, or 
any substantially similar regulatory action.
    (b) Definition of Pregnancy Center.--In subsection (a), the term 
``pregnancy center'' means any organization, such as a pregnancy 
resource center, pregnancy help center or organization, or pregnancy 
medical center, that--
            (1) supports protecting the life of the mother and the 
        unborn child; and
            (2) offers resources and services to mothers, fathers, and 
        families, including but not limited to relationship counseling, 
        prenatal and pregnancy education, pregnancy testing, diapers, 
        baby clothes, or material supports.

            Passed the House of Representatives January 18, 2024.

            Attest:

                                                                 Clerk.
118th CONGRESS

  2d Session

                               H. R. 6918

_______________________________________________________________________

                                 AN ACT

To prohibit the Secretary of Health and Human Services from restricting 
                     funding for pregnancy centers.
```
N OTE : This disposition is nonprecedential.



# United States **Court of Appeals** 
**for the Federal Circuit**

______________________

HORIZON THERAPEUTICS , LLC, Appellant

v.

ANDREI IANCU, UNDER SECRETARY OF

COMMERCE FOR INTELLE CTUAL PROPERTY

AND DIRECTOR OF THE UNIT ED STATES

PATENT AND TRADEMARK OFFICE

, Intervenor

______________________

2018

- 1225

______________________

Appeal from the United States Patent and Trademark Office, Patent Trial and Appeal Board in No. IPR2016

- 00829.

_________________ _____

JUDGMENT

______________________

R OBERT F RITZ G REEN

, Green, Griffith & Borg

- Breen LLP, Chicago, IL, argued for appellant. Also represented by C ARYN B ORG

- B REEN

, E MER L OUISE S IMIC ; M ATTHEW C.

P HILLIPS , Laurence & Phillips IP Law LLP, Portland, OR.

K

AKOLI C APRIHAN

, Office of the Solicitor, United States Patent and Trademark Office, Alexandria, VA, argued forintervenor. Also represented by T HOMAS W. K RAUSE

, J OSEPH M ATAL

, M EREDITH H OPE S CHOEN FELD

.

______________________

T HIS C AUSE ha ving been heard and considered, it is

O RDERED and A DJUDGED :

P ER C URIAM (N EWMAN

, C LEVENGER

, and R EYNA

, Circuit Judges ).

AFFIRMED. See Fed . Cir. R. 36.

E NTERED BY O RDER OF THE C OURT

October 10, 2019 /s/ Peter R. Marksteiner

Date Peter R. Marksteiner

Clerk of Court
[Federal Register Volume 87, Number 43 (Friday, March 4, 2022)]
[Notices]
[Page 12447]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-04538]


-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

[Project No. 13806-012]


5440 Hydor, Inc.; Ampersand Brooklyn Dam Hydro, LLC; Notice of 
Transfer of Exemption

    1. On January 24, 2022, 5440 Hydro, Inc., exemptee for the 600-
Kilowatt Brooklyn Dam Hydroelectric Project No. 13806, filed a letter 
notifying the Commission that the project was transferred from 5440 
Hydro, Inc. to Ampersand Brooklyn Dam Hydro, LLC. The exemption from 
licensing was originally issued on August 14, 2015.\1\ The project is 
located on the Upper Ammonoosuc River, Coos County, New Hampshire. The 
transfer of an exemption does not require Commission approval.
---------------------------------------------------------------------------

    \1\ 5440 Hydro, Inc., 152 FERC ] 62,113 (2015).
---------------------------------------------------------------------------

    2. Ampersand Brooklyn Dam Hydro, LLC is now the exemptee of the 
Brooklyn Dam Hydroelectric Project No. 13806. All correspondence must 
be forwarded to: Mr. Amit Pinjani, Asset Manager, Ampersand Brooklyn 
Dam Hydro, LLC, 717 Atlantic Avenue, Suite 1A, Boston, MA 02111, Email: 
<a href="/cdn-cgi/l/email-protection#56373b3f2216373b2633242537383233383324312f7835393b"><span class="__cf_email__" data-cfemail="1a7b77736e5a7b776a7f68697b747e7f747f687d6334797577">[email protected]</span></a>.

    Dated: February 25, 2022.
Kimberly D. Bose,
Secretary.
[FR Doc. 2022-04538 Filed 3-3-22; 8:45 am]
BILLING CODE 6717-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
<PAGE>
 
                            STERLING COMMERCE, INC.                 EXHIBIT 11.1
                   COMPUTATION OF EARNINGS (LOSS) PER SHARE
                 (IN THOUSANDS, EXCEPT PER SHARE INFORMATION)
<TABLE>
<CAPTION>
                                              THREE MONTHS          NINE MONTHS
                                          ENDED JUNE 30, 1997   ENDED JUNE 30, 1997
                                          -------------------   -------------------
<S>                                       <C>                   <C>
Primary:
Average shares outstanding..............          89,492               81,516
Net effect of dilutive stock                             
 options-based on the treasury stock                                          
 method using average market price......                                2,150 
                                                 -------              -------
Total...................................          89,492               83,666
                                                 =======              =======
                                                         
Net income (loss).......................         $(7,476)             $27,401
                                                 =======              =======

Per share amount........................         $  (.08)             $   .33
                                                 =======              =======
                                                         
Fully diluted:                                           
Average shares outstanding..............          89,492               81,516
Net effect of dilutive stock                             
 options-based on the treasury stock                                          
 method using the higher of average or                   
 quarter-end market price...............                                2,564
                                                 -------              -------
Total...................................          89,492               84,080
                                                 =======              =======
                                                         
Net income (loss).......................         $(7,476)             $27,401
                                                 =======              =======
                                                         
Per share amount........................         $  (.08)             $   .33
                                                 =======              =======
</TABLE>

Computational Note:

     In connection with the computation of loss per share for the three months
ended June 30, 1997, all otherwise dilutive common share equivalents have been
excluded because the impact on the Company's net loss per share is anti-
dilutive.  In the absence of this net loss, 1,936 and 2,633 additional dilutive
common share equivalents would be included in the computation of primary and
fully-diluted earnings per share, respectively.
Exhibit 23

AUDITORS CONSENT

To Yak Communications Inc. and Subsidiaries

We consent to the incorporation by reference in the Registration Statement on Form S-3 (No. 333-114084) of Yak Communications Inc. and subsidiaries of our report dated
September 15, 2005, except for Note 5A as to which the date is September 27, 2005, and Notes 5B to 5F as to which the date is March 31, 2006, which appears on page 79 of this annual report on Form 10-K/A for the year ended June 30, 2005.



|                                                    
|----------------------------------------------------
|                                                    
|/s/ Horwath Orenstein LLP                           
|                                                    
|Chartered Accountants Toronto, Canada April 21, 2006
**Exhibit 32.1**

**CERTIFICATION PURSUANT TO**

**18 U.S.C. SECTION 1350,**

**AS ADOPTED PURSUANT TO**

**SECTION 906OF THE SARBANES-OXLEY ACT OF 2002**

In connection with the Annual Report on Form 10-K of drugstore.com, inc. (the “Company”)for the period ending December 30, 2007, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Dawn Lepore, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, asadopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that: 

(1) The Report fully complies with the requirementsof section 13(a) or 15(d) of the Securities Exchange Act of 1934; and 

(2) The information contained in the Report fairlypresents, in all material respects, the financial condition and result of operations of the Company. 

 

A signed original of this written statement required by Section 906 has been providedto drugstore.com, inc. and will be retained by drugstore.com, inc. and furnished to the Securities and Exchange Commission or its staff upon request. 

March 13, 2008
Exhibit 32.2

CERTIFICATION OF CHIEF FINANCIAL OFFICER

PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002

Pursuant to 18 U.S.C. § 1350, as created by Section 906 of the Sarbanes-Oxley Act of 2002,
the undersigned officer of ArthroCare Corporation (the Company) hereby certifies, to such officers knowledge, that:



| | (i) | The accompanying Quarterly Report on Form 10-Q of the Company for the three and nine months ended September 30, 2006 (the Report) fully complies with the
requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and
| | --- | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



| | (ii) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
| | ---- | ----------------------------------------------------------------------------------------------------------------------------------------------------



|                        |  |                        
|----------------------- |  | -----------------------
|Dated: October 31, 2006 |  | /s/ Michael Gluk       
|                        |  | Michael Gluk           
|                        |  | Chief Financial Officer

A signed original of this written statement required by Section 906 of the Sarbanes-Oxley Act
of 2002 (Section 906), or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of the written statement required by Section 906, has been provided
to ArthroCare Corporation and will be retained by ArthroCare Corporation and furnished to the Securities and Exchange Commission or its staff upon request.
<TABLE> <S> <C>


<ARTICLE>                     5
<LEGEND>I
THIS  SCHEDULE  CONTAINS  SUMMARY  FINANCIAL   INFORMATION  EXTRACTED  FROM  THE
COMPANY'S  FINANCIAL  STATEMENTS FOR THE THREE MONTHS ENDED JUNE 27, 1997 AND IS
QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                         MAR-28-1997
<PERIOD-END>                              JUN-27-1997
<CASH>                                         99,924
<SECURITIES>                                        0
<RECEIVABLES>                               3,308,746
<ALLOWANCES>                                 (146,551)
<INVENTORY>                                 9,781,012
<CURRENT-ASSETS>                           13,807,000
<PP&E>                                      2,599,381
<DEPRECIATION>                             (1,875,623)
<TOTAL-ASSETS>                             18,567,933
<CURRENT-LIABILITIES>                       5,404,366
<BONDS>                                             0
<PREFERRED-MANDATORY>                               0
<PREFERRED>                                         0
<COMMON>                                       47,018
<OTHER-SE>                                 13,116,549
<TOTAL-LIABILITY-AND-EQUITY>               18,567,933
<SALES>                                     6,216,558
<TOTAL-REVENUES>                            6,216,558
<CGS>                                       5,122,640
<TOTAL-COSTS>                               5,122,640
<OTHER-EXPENSES>                              292,028
<LOSS-PROVISION>                                    0
<INTEREST-EXPENSE>                             72,150
<INCOME-PRETAX>                                25,209
<INCOME-TAX>                                  (11,921)
<INCOME-CONTINUING>                            37,130
<DISCONTINUED>                                      0
<EXTRAORDINARY>                                     0
<CHANGES>                                           0
<NET-INCOME>                                   37,130
<EPS-PRIMARY>                                     .02
<EPS-DILUTED>                                     .02
        


</TABLE>